Eiger BioPharmaceuticals, Inc. (EIGRQ)
OTCMKTS: EIGRQ · Delayed Price · USD
12.50
0.00 (0.00%)
Jul 19, 2024, 4:00 PM EDT - Market open
Eiger BioPharmaceuticals Employees
Eiger BioPharmaceuticals had 25 employees as of December 31, 2023. The number of employees decreased by 31 or -55.36% compared to the previous year.
Employees
25
Change (1Y)
-31
Growth (1Y)
-55.36%
Revenue / Employee
$630,920
Profits / Employee
-$2,998,520
Market Cap
18.51M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
Danaher | 63,000 |
EIGRQ News
- 4 weeks ago - Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar - Reuters
- 3 months ago - Healthcare stocks fade as obesity-drug optimism fades - Market Watch
- 3 months ago - Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection - GlobeNewsWire
- 6 months ago - Eiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan - PRNewsWire
- 7 months ago - Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock Split - PRNewsWire
- 9 months ago - Eiger BioPharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update - PRNewsWire
- 11 months ago - Eiger to Discontinue Phase 3 LIMT-2 Trial of Peginterferon Lambda in Patients with Chronic Hepatitis Delta - PRNewsWire
- 11 months ago - Eiger BioPharmaceuticals to Present at H.C. Wainwright 25th Annual Global Investment Conference - PRNewsWire